The dissolution rate is the rate-limiting step for Biopharmaceutics Classification System (BCS) class II drugs to enhance their in vivo pharmacokinetic behaviors. There are some factors affecting the dissolution rate, such as polymorphism, particle size, and crystal habit. In this study, to improve the dissolution rate and enhance the in vivo pharmacokinetics of sorafenib tosylate (Sor-Tos), a BCS class II drug, two crystal habits of Sor-Tos were prepared. A plate-shaped crystal habit (ST-A) and a needle-shaped crystal habit (ST-B) were harvested by recrystallization from acetone (ACN) and n-butanol (BuOH), respectively. The surface chemistry of the two crystal habits was determined by powder X-ray diffraction (PXRD) data, molecular modeling, and face indexation analysis, and confirmed by X-ray photoelectron spectroscopy (XPS) data. The results showed that ST-B had a larger hydrophilic surface than ST-A, and subsequently a higher dissolution rate and a substantial enhancement of the in vivo pharmacokinetic performance of ST-B. 相似文献
The synthesis of trifluoromethylated cyclopropenes is often associated with important applications in drug discovery and functional materials. In this report, we describe the use of readily available chiral rhodium(II) catalysts for a highly efficient asymmetric cyclopropenation reaction of fluorinated donor–acceptor diazoalkanes with a broad variety of aliphatic and aromatic alkynes. Further studies highlight the unique reactivity of fluorinated donor–acceptor diazoalkanes in the synthesis of oligo-cyclopropenes. Subsequent C−H functionalization of trifluoromethyl cyclopropenes furnishes densely substituted cyclopropene frameworks and also allows the alternative synthesis of bis-cyclopropenes. 相似文献
In this paper, we propose a heuristic search algorithm based on maximum conflicts to find a weakly stable matching of maximum size for the stable marriage problem with ties and incomplete lists. The key idea of our approach is to define a heuristic function based on the information extracted from undominated blocking pairs from the men’s point of view. By choosing a man corresponding to the maximum value of the heuristic function, we aim to not only remove all the blocking pairs formed by the man but also reject as many blocking pairs as possible for an unstable matching from the women’s point of view to obtain a solution of the problem as quickly as possible. Experiments show that our algorithm is efficient in terms of both execution time and solution quality for solving the problem.
The paper examines the supramolecular effects at play during photosensitization by carboxylated Ru(II) sensitizers, both by experiment and by modeling. Experimentally, twelve Ru(II) complexes of pyrazolylpyridine and polypyridine ligands, including two benchmark complexes and two new species, were assessed as photosensitizers by measurement of the kinetics of methyl viologen cation radical (MV(*)(+)) generation through an oxidative, photoinduced electron transfer (PET) to methyl viologen (MV(2+)) under continuous irradiation in the presence of a sacrificial reductant. All complexes, luminescent or not, produced measurable amounts of MV(*)(+) in CH(3)CN. The assessment protocol was found to be useful with sensitizers of widely varying excited-state lifetimes (tau) as well as being easier and faster than conventional approaches. The seven sensitizers bearing peripheral COOH groups were found to be significantly more active than their non-carboxylated analogues, which is consistent with ionization of the COOH groups and electrostatic promotion of PET. Only the luminescent complexes were active in aqueous solvents, where tau appears to be the dominant effector. The benefits are exemplified by the singly carboxylated [Ru(H1)(bpy)(2)](2+) (H1 is 1-(4-carboxyphenyl)-3-(2-pyridyl)-4,5,6,7-tetrahydroindazole), a weakly luminescent sensitizer that was less active in aqueous solvents than [Ru(bpy)(3)](2+) (bpy is 2,2'-bipyridine), but which became the better sensitizer in CH(3)CN. Computationally, electrostatic field and dissociation energy calculations demonstrated that even a single peripheral COO(-) substituent suffices to provide supramolecular assistance: it defines a spheric "bubble" of electrostatically attractive space that is sufficiently large to allow the supramolecular preassociation of MV(2+), which provides an entropic advantage to PET that reduces the importance of tau in organic solvent. Calculations also show that the PET is electrostatically favored over its reverse (BET) even with cationic sensitizers because the "bubble" contracts after PET while the bulk medium becomes more repulsive, and favorable cation exchanges can occur to effect post-PET dissociation. Two peripheral COO(-) groups can define a two-point binding site for MV(2+) in an attractive sector of space that contracts to a kidney-shaped "bubble" after PET. This enables unimolecular PET while the reverse reaction remains bimolecular. The resultant benefits are illustrated with [Ru(Na1)(2)(bpy)](2+), a very weakly luminescent sensitizer that was totally inactive in H(2)O but appreciably active in CH(3)CN, despite the need to displace Na(+) in order to derive any electrostatic benefit. The Marcus free energies of activation for PET and BET corroborate the benefits of carboxylation, solvent, and other factors and correlated with the experimental rate constants. 相似文献
Hepatocellular carcinoma (HCC) is a lethal cancer with limited therapeutic options, and standard therapy with sorafenib provides only modest survival benefits. Fibroblast growth factor 19 (FGF19) has been proposed as a driver oncogene, and targeting its receptor, FGFR-4, may provide a better alternative to standard therapy for patients with FGF19-driven tumors. Sixty-three HCC patient-derived xenograft (PDX) models were screened for FGF19 expression. Mice bearing high and low FGF19-expressing tumors were treated with FGF401 and/or vinorelbine, and the antitumor activity of both agents was assessed individually and in combination. Tumor vasculature and intratumoral hypoxia were also examined. High FGF19 expression was detected in 14.3% (9 of 63) of the HCC models tested and may represent a good target for HCC treatment. FGF401 potently inhibited the growth of high FGF19-expressing HCC models regardless of FGF19 gene amplification. Furthermore, FGF401 inhibited the FGF19/FGFR-4 signaling pathway, cell proliferation, and hypoxia, induced apoptosis and blood vessel normalization and prolonged the overall survival (OS) of mice bearing high FGF19 tumors. FGF401 synergistically acted with the microtubule-depolymerizing drug vinorelbine to further suppress tumor growth, promote apoptosis, and prolong the OS of mice bearing high FGF19 tumors, with no evidence of increased toxicity. Our study suggests that a subset of patients with high FGF19-expressing HCC tumors could benefit from FGF401 or FGF401/vinorelbine treatment. A high level of FGF19 in a tumor may serve as a potential biomarker for patient selection.Subject terms: Cancer models, Targeted therapies相似文献